动脉瘤性蛛网膜下腔出血手术患者血细胞比容漂移与结局
在一所大学医院开展的队列研究中,671例动脉瘤性蛛网膜下腔出血(aSAH)手术夹闭患者中118例(17.6%)发生院内血细胞比容漂移超过25%。多因素回归分析显示血细胞比容漂移升高与死亡风险显著增加相关(aOR:2.12,95%CI:1.14至3.97;P=0.019),匹配分析结果相似(aOR:2.07,95%CI:1.05至4.10;P=0.036)。
要点
- 671例aSAH手术夹闭患者中118例(17.6%)发生院内血细胞比容漂移超过25%。
- 血细胞比容漂移升高与死亡风险增加独立相关(aOR:2.12,95%CI:1.14至3.97;P=0.019)。
- 血细胞比容漂移每增加10%,死亡调整比值比为1.31(95%CI:1.08至1.61;P=0.008)。
核心结论
- 向下血细胞比容漂移超过25%可独立预测aSAH手术患者的死亡。
- 这些发现强调监测血细胞比容和管理贫血在该患者群体中的重要性。
研究设计与样本
- 在一所大学医院开展的队列研究,纳入诊断为aSAH的成年患者。
- 研究期间共671例aSAH患者,其中118例(17.6%)发生院内血细胞比容漂移超过25%。
- 采用倾向性评分匹配按基线特征对齐患者,并使用净重分类改善(NRI)评估和比较各模型的区分能力。
主要发现
- 多因素回归分析调整后,血细胞比容漂移升高的患者死亡比值比显著增加(aOR:2.12,95%CI:1.14至3.97;P=0.019)。
- 匹配分析结果相似(aOR:2.07,95%CI:1.05至4.10;P=0.036)。
- 将血细胞比容漂移纳入模型显著改善了死亡预测的NRI(P<0.0001)。
- 当院内血细胞比容漂移作为连续变量时,血细胞比容漂移每增加10%,死亡的调整比值比为1.31(95%CI:1.08至1.61;P=0.008)。
关键数值与推荐
- 院内血细胞比容漂移超过25%定义为血细胞比容漂移升高。
- 主要终点为随访死亡率。
临床怎么用
- 原文结论强调监测血细胞比容和管理贫血在aSAH手术患者中的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a paucity of conclusive evidence regarding the impact of downward drift in hematocrit levels among patients who have undergone surgical clipping for aneurysmal subarachnoid hemorrhage (aSAH). This study endeavors to explore the potential association between hematocrit drift and mortality in this specific patient population. METHODS: A cohort study was conducted, encompassing adult patients diagnosed with aSAH at a university hospital. The primary endpoint was follow-up mortality. Propensity score matching was employed to align patients based on their baseline characteristics. Discrimination capacity across various models was assessed and compared using net reclassification improvement (NRI). RESULTS: Among the 671 patients with aSAH in the study period, 118 patients (17.6%) experienced an in-hospital hematocrit drift of more than 25%. Following adjustment with multivariate regression analysis, patients with elevated hematocrit drift demonstrated significantly increased odds of mortality (aOR: 2.12, 95% CI: 1.14 to 3.97; P = 0.019). Matching analysis yielded similar results (aOR: 2.07, 95% CI: 1.05 to 4.10; P = 0.036). The inclusion of hematocrit drift significantly improved the NRI (P < 0.0001) for mortality prediction. When in-hospital hematocrit drift was served as a continuous variable, each 10% increase in hematocrit drift corresponded to an adjusted odds ratio of 1.31 (95% CI 1.08-1.61; P = 0.008) for mortality. CONCLUSIONS: In conclusion, the findings from this comprehensive cohort study indicate that a downward hematocrit drift exceeding 25% independently predicts mortality in surgical patients with aSAH. These findings underscore the significance of monitoring hematocrit and managing anemia in this patient population.
引用
- Wang X, Chen W, Qiu X, et al. Hematocrit drift and outcomes in surgical patients with aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien). 2024. PMID: 38703244. doi:10.1007/s00701-024-06097-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。